Skip to main content
Sign In
 

Gastrointestinal Eosinophilic Diseases Program - Research


 

The Gastrointestinal Eosinophilic Diseases Program (GEDP) research team performs novel research focusing on eosinophils’ impact on the gastrointestinal tract. Studies center on the mechanisms that eosinophils relate to resident cells of the intestinal tract and how these relationships contribute to host health and disease.

The Gastrointestinal Eosinophilic Diseases Program (GEDP) research team is a part of the Mucosal Inflammation Program (MIP) in the Gastroenterology Division at the University of Colorado School of Medicine (CU SOM) that is directed by Dr. Sean Colgan. The MIP carries an overall theme of determining mechanisms of inflammation at a variety of mucosal surfaces including the GI tract and the lung.  Taken together, the Gastrointestinal Eosinophilic Diseases Program and Mucosal Inflammation Program unite a unique blend of basic and clinical investigators. This integration of basic and clinical sciences and multidisciplinary approach fosters collaboration between key personnel from different divisions of CU SOM to provide outstanding patient care and novel research outcomes.

 

Related Websites and Additional Information


Visit the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Web site, for links to many online presentations, and slideshows.

Visit the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) website​ for information about ongoing research studies and to join the Contact Registry for patients with eosinophilic gastrointestinal diseases.

The GEDP consists of four investigators.

Dr. Kelley Capocelli is an Assistant Professor of Pathology whose research interests include the pathophysiology of eosinophilic gastrointestinal diseases, transplant pathology, and hemovigilance in transfusion medicine.

Dr. Sophie Fillon is an Assistant Professor of Pediatrics with an expertise in microbiology, host pathogen interaction, and innate defense mechanisms. Dr. Fillon’s research goal is identifying the role of bacteria in the pathogenesis of eosinophilic gastrointestinal diseases.

Dr. Glenn Furuta is a physician-scientist whose work examines the role of eosinophils' GI function.

Dr. Joanne Masterson​ is an Assistant Professor of Pediatrics with a research focus on eosinophils and intestinal remodeling. The goal of her studies is to identify novel therapeutic targets and strategies to prevent, treat, and cure intestinal diseases.